Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Explore Zucara Therapeutics' study on ZT-01, aiming to reduce night-time hypoglycemia in type 1 diabetes by enhancing glucagon production. Join if you meet the criteria.
Explore the emerging effects of GLP-1 receptor agonists on glycemic control and weight management, including their potential impact on birth control pill absorption and...
Glucagon is a hormone produced by the pancreas that raises blood sugar levels by prompting the liver to convert stored glycogen into glucose. It is essential for glucose...
Uncover the varied impacts of GLP-1 and incretin therapies on mental health, quality of life, addiction, fatigue, and physical changes.
Most people with diabetes know when they are low, but others have difficulty detecting it or are completely unaware. This is known as hypoglycemia unawareness.
Temporary shortages of the fast-acting insulin Humalog and its generic version may complicate diabetes care for people using pumps, automated insulin delivery, or on...
For the first time, Medicare is allowed to cover Wegovy, but only if prescribed to reduce the risk of serious cardiovascular events.
Discover the latest in gestational diabetes management, including CGM technology, screening debates, and possible new treatments like inhaled insulin.
The daily pill Rezdiffra is the first treatment for people with a type of liver disease known as MASH, which affects up to 20% of people with type 2 diabetes.
The FDA has approved Wegovy (semaglutide) for reduction of major adverse cardiovascular events (MACE) in people with obesity and overweight and without diabetes, based...
In new studies presented at ATTD, CGM used with GLP-1s led to greater A1C reductions than GLP-1s alone.
Novo Nordisk’s FLOW trial was stopped early after results showed that Ozempic (semaglutide) slows progression of kidney disease in people with type 2 diabetes and CKD.
Exploring metformin as a treatment for gestational diabetes: This article delves into the efficacy, safety, and patient satisfaction of metformin compared to insulin,...
A recent study supports the idea that metformin may have a role in dementia prevention. Studies are ongoing to provide a definitive answer.
Every February, the Spare a Rose campaign raises funds to provide insulin and other diabetes supplies to people with type 1 in under-resourced countries. Spread the word...
Discover the hidden risks of diabetic ketoacidosis (DKA) in insulin-treated diabetes. Learn about euglycemic DKA, triggered by SGLT-2 inhibitors.
GLP-1 drugs like Ozempic show promise in addiction treatment, with ongoing research and clinical trials redefining recovery approaches.
2024 brings insulin price cuts but analysis shows 775 med price hikes, including diabetes drugs. Future price negotiations and affordability resources highlighted
Explore strategies for managing post-meal blood sugar spikes in diabetes, including adjusting insulin doses, dietary changes, and physical activity. Learn the importance...
New study in Diabetes, Obesity and Metabolism reveals Brenzavvy, an affordable SGLT-2 inhibitor for type 2 diabetes, is heart-safe and effective. It lowers blood sugar...

Pages